These data confirm our previous findingsin vivo(Iliff et al

These data confirm our previous findingsin vivo(Iliff et al. release (p<0.01 ANOVA, n=6). 14,15-EEZE likewise attenuated capsaicin-evoked CGRP release from trigeminal ganglion neurons (p<0.05 ANOVA, n=6). Similarly, pre-treatment with the CYP epoxygenase inhibitor attenuated stimulation-evoked CGRP Plumbagin release. These data demonstrate that EETs are endogenous constituents of rat trigeminal ganglion neurons and suggest that they may act as intracellular regulators of neuropeptide release, which may have important clinical implications for treatment of migraine, stroke and vasospasm after subarachnoid hemorrhage. Keywords:cytochrome P450 epoxygenase, epoxyeicosatrienoic acid, perivascular nerves, CGRP, material P, TRPV1 == Introduction == Neurons of the trigeminal ganglia provide the sensory innervation of the head Plumbagin and face, in addition to contributing to the perivascular nerve supply of the meningeal and cerebral surface vasculature (Edvinsson & Uddman 2005). Stimulation of these perivascular trigeminal afferents results in both peripheral and central release of neuropeptide transmitters, including calcitonin gene-related peptide (CGRP) and material P (SP), that mediate peripheral vasodilation and inflammation as well as central pain transmission (Edvinsson & Uddman 2005). It is the activation and sensitization of these fibers that underlies the dural inflammation and pain associated with migraine headache (Durham 2006,Edvinsson & Uddman 2005). The identification of the transmitters active within the so-called trigeminovascular system, and those molecular pathways that change their activity, has driven the recent progress in acute migraine treatment and remains critical Plumbagin to further progress in primary headache therapy (Durham 2008,Benemeiet al.2007). We recently demonstrated that this functional regulation of the cerebral vasculature by perivascular vasodilator fibers, including primary trigeminal afferents, involves the epoxyeicosanoid signaling pathway (Iliffet al.2009). Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites of cytochrome P450 (CYP) epoxygenase enzymes resulting from the addition of an epoxide to either one of the four arachidonic acid double bonds, generating the four distinct EETs regiosomers: 5,6-EET, 8,9-EET, 11,12-EET and 14,15-EET (Physique 1A) (Roman 2002,Zeldin 2001). These lipid signaling molecules are most commonly regarded as potent vasodilators in a number of vascular beds, including in the cerebral circulation (Earleyet al.2005,Elliset al.1991,Elliset al.1990,Iliff et al. 2009) were they are produced both by the vascular endothelium (Medhoraet al.2001) and by perivascular astrocytes (Alkayedet al.1997,Alkayedet al.1996), and contribute to the physiological regulation of cerebral blood flow (CBF) (Koehleret al.2006,Penget al.2002,Penget al.2004). The cellular levels and biological activity of EETs are regulated through their hydrolysis to less active dihydroxyeicosatrienoic acids (DHETs), a process that is catalyzed by the enzyme soluble epoxide hydrolase (sEH,Physique 1A) (Sadoshimaet al.1986,Spectoret al.2004,Zeldin 2001). == Physique 1. Expression of CYP epoxygenase and soluble epoxide hydrolase in primary trigeminal ganglion neurons. == (A) Cytochrome P450 epoxygenase enzymes of the CYP-2C and CYP-2J families convert arachidonic acid to four epoxyeicosatrienoic acid (EET) regio-isomers: 5,6-EET, 8,9-EET, 11,12-EET and 14,15-EET (shown). EETs are degraded by soluble epoxide hydrolase (sEH) to produce dihydroxyeicosatrienoic acids (DHETs). (BI) Immunocytochemistry of rat primary trigeminal ganglion Rabbit polyclonal to Osteopontin neurons (TGNs), day 4 in culture. CYP-2J epoxygenase is usually broadly expressed in primary TGNs (B), including those expressing the neuropeptides calcitonin gene-related peptide (CGRP, C) and material P (SP, D), in addition to the transient receptor potential vanilloid-1 (TRPV1) cation channel (E). (F) Soluble epoxide hydrolase is usually expressed in TGNs. sEH-immunoreactivity co-localizes with the neuropeptides CGRP (G) and material P (H), in addition to the TRPV1 cation channel (I). All images are representative of at least three biological replicates. Scale bars: 60 m. Our group reported the expression Plumbagin of two distinct EETs-synthetic CYP epoxygenases, CYP-2J3 and CYP-2J4, in addition to sEH, in the neurons of the rat trigeminal ganglia, including those that contribute to the perivascular innervation of the cerebral surface vasculature (Iliffet al.2007,Iliff et al. 2009). This obtaining indicates that these neurons possess the biochemical machinery for the synthesis and regulation of vasoactive EETs. In subsequent experiments utilizing two distinctin vivomodels Plumbagin of neurogenic cerebral vasodilation, the increases in CBF resulting from perivascular vasodilator nerve activation were blocked by the EETs antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE). These data suggest that EETs signaling contributes to the peripheral neuroeffector actions of these perivascular neurons. The specific role of EETs signaling in the effector actions of primary trigeminal afferents, however, remains unexplored. Given the established vasodilator effects of EETs in the cerebral circulation (Earley et al. 2005,Ellis et al. 1991,Ellis et al. 1990,Iliff et al. 2009), one possibility is usually that EETs represent a releasable lipid-based vasoactive paracrine factor, synthesized in, and released from, trigeminal ganglia neurons (TGNs) in parallel with other transmitters such as the vasoactive.